Evercore Wealth Management, LLC Eli Lilly & CO Transaction History

Evercore Wealth Management, LLC

$6.66 Billion
Q3 2024

A detailed history of Evercore Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Evercore Wealth Management, LLC holds 37,266 shares of LLY stock, worth $27.9 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

37,266

Previous 40,486 7.95%

Holding current value

$27.9 Million

Previous $36.7 Million 9.93%

% of portfolio

0.5%

Previous 0.58%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $2.49 Million - $3.09 Million	-3,220 Reduced 7.95%	37,266 $33 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $37,693 - $47,270	-52 Reduced 0.13%	40,486 $36.7 Million
Q1 2024 May 15, 2024	SELL	$592.2 - $792.28 $3.24 Million - $4.33 Million	-5,469 Reduced 11.89%	40,538 $31.5 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $438,008 - $516,354	-834 Reduced 1.78%	46,007 $26.8 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $325,155 - $448,276	-748 Reduced 1.57%	46,841 $25.2 Million
Q2 2023 Aug 04, 2023	SELL	$350.74 - $468.98 $243,062 - $325,003	-693 Reduced 1.44%	47,589 $22.3 Million
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $362,505 - $425,744	-1,167 Reduced 2.36%	48,282 $16.6 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $38,907 - $45,335	-121 Reduced 0.24%	49,449 $18.1 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $22,236 - $25,340	-75 Reduced 0.15%	49,570 $16 Million
Q2 2022 Aug 15, 2022	SELL	$278.73 - $327.27 $455,444 - $534,759	-1,634 Reduced 3.19%	49,645 $16.1 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $311,433 - $387,032	-1,327 Reduced 2.52%	51,279 $14.7 Million
Q4 2021 Feb 14, 2022	SELL	$224.85 - $279.04 $404,730 - $502,272	-1,800 Reduced 3.31%	52,606 $14.5 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $412,176 - $507,240	-1,860 Reduced 3.31%	54,406 $12.6 Million
Q2 2021 Aug 16, 2021	SELL	$180.55 - $233.54 $513,664 - $664,421	-2,845 Reduced 4.81%	56,266 $12.9 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $401,433 - $519,674	-2,443 Reduced 3.97%	59,111 $11 Million
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $160,465 - $212,334	-1,230 Reduced 1.96%	61,554 $10.4 Million
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $35,092 - $40,591	240 Added 0.38%	62,784 $9.29 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $24,009 - $28,895	-176 Reduced 0.28%	62,544 $10.3 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $973,114 - $1.2 Million	-8,174 Reduced 11.53%	62,720 $8.7 Million
Q4 2019 Feb 13, 2020	SELL	$106.92 - $132.43 $49,931 - $61,844	-467 Reduced 0.65%	70,894 $9.32 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $186,882 - $203,280	-1,750 Reduced 2.39%	71,361 $7.98 Million
Q2 2019 Aug 13, 2019	BUY	$110.79 - $129.32 $182,360 - $212,860	1,646 Added 2.3%	73,111 $8.1 Million
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $206,146 - $242,649	-1,852 Reduced 2.53%	71,465 $9.27 Million
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $69,682 - $78,065	-658 Reduced 0.89%	73,317 $8.49 Million
Q3 2018 Nov 13, 2018	SELL	$85.86 - $107.31 $327,727 - $409,602	-3,817 Reduced 4.91%	73,975 $7.94 Million
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $4.08 Million - $4.68 Million	53,840 Added 224.78%	77,792 $6.64 Million
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $31,168 - $36,792	-420 Reduced 1.72%	23,952 $1.85 Million
Q4 2017 Feb 13, 2018	SELL	$81.94 - $87.89 $119,632 - $128,319	-1,460 Reduced 5.65%	24,372 $2.06 Million
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $1.99 Million - $2.21 Million	25,832	25,832 $2.21 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Evercore Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evercore Wealth Management, LLC with notifications on news.

Account

Evercore Wealth Management, LLC Eli Lilly & CO Transaction History